Nattokinase Market Size & Growth Forecast 2026–2035, By Segments (Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Nattokinase Market size was over USD 34.42 Million in 2025 and is likely to grow at a 3.2% CAGR between 2026 and 2035, surpassing USD 47.16 Million by 2035. The industry revenue for 2026 is assessed at USD 35.35 million.
Get more details on this report
Request Free Sample ReportNattokinase Market Intelligence Snapshot
Regional Market Dynamics
- Asia Pacific led the market in 2025 due to strong familiarity with fermented soy products, a robust manufacturing base, and steady demand for enzyme-based wellness products.
- North America is projected to grow at a 3.65% CAGR, supported by rising interest in preventive health, broader supplement adoption, and expanding retail and e-commerce availability.
Segment Momentum
- Nutraceuticals lead with 47.91% share due to strong consumer demand for daily cardiovascular wellness supplements and wide availability in capsule and tablet formulations for routine use.
- Pharmaceuticals are growing fastest due to rising interest in clinically positioned cardiovascular treatments and structured medical use cases beyond general wellness supplementation.
Market Expansion Drivers
- Rising cardiovascular health awareness increasing demand for natural fibrinolytic dietary supplements.
- Growing consumer preference for natural functional ingredients accelerating supplement market penetration.
- Expanding use of nattokinase in functional foods and skincare formulations broadening commercial applications.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Leading companies in the nattokinase market include Japan Bio Science Laboratory Co., Ltd. (Japan), Novonesis A/S (Denmark), BIO-CAT, Inc. (U.S.), Creative Enzymes (U.S.), Daiwa Pharmaceutical Co., Ltd. (Japan), Contek Life Science Co., Ltd. (China), Sungen Bioscience Co., Ltd. (Taiwan), Weidan Biotechnology Co., Ltd. (China), Bioven Ingredients (Spain), Eiffel Biotech Co., Ltd. (China).Regional and Segment Outlook
Asia PacificMarket Growth Drivers and Industry Trends
As consumer attention shifts toward preventive heart health, the nattokinase market is seeing stronger demand from buyers seeking non-pharmaceutical options associated with circulation support and fibrin management. This awareness changes purchasing behavior in practical ways: consumers are more likely to research ingredient-specific benefits, compare formulations positioned around cardiovascular wellness, and choose supplements that align with daily preventive routines rather than episodic use. That pattern supports repeat purchases, encourages premium positioning around purity and efficacy, and gives brands a clearer basis for product differentiation in a category where trust and health relevance heavily influence conversion.
Growing consumer preference for natural functional ingredients accelerating supplement market penetration
The move away from synthetic-sounding additives and toward recognizable bioactive ingredients is increasing market penetration for the nattokinase market, particularly in wellness segments where label transparency shapes buying decisions. Nattokinase fits well with supplement portfolios built around clean-label, naturally derived, and multifunctional positioning, which makes it easier for manufacturers to introduce it in capsules, combination formulas, and condition-specific products. As retailers and digital sellers give more visibility to natural wellness solutions, this preference directly influences assortment strategy, widens consumer access, and supports broader adoption beyond niche cardiovascular supplement users.
Expanding use of nattokinase in functional foods and skincare formulations broadening commercial applications
Commercial interest in applying this enzyme beyond capsules is supporting market development for the nattokinase market by creating new formulation pathways in food, beverage, and topical wellness products. In functional foods, nattokinase allows manufacturers to embed cardiovascular-support positioning into more routine consumption formats, which can reduce reliance on traditional supplement channels and bring the ingredient into everyday health occasions. In skincare, its inclusion reflects growing interest in bioactive ingredients linked to skin vitality and microcirculation-related benefits, encouraging cross-category product innovation and drawing demand from formulators looking for differentiated natural actives.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cardiovascular health awareness increasing demand for natural fibrinolytic dietary supplements | 1.80% | Moderate | North America, Asia Pacific | High | Near Term |
| Growing consumer preference for natural functional ingredients accelerating supplement market penetration | 1.60% | Low | Europe, North America | High | Near Term |
| Expanding use of nattokinase in functional foods and skincare formulations broadening commercial applications | 1.20% | Moderate | Asia Pacific, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
Asia Pacific held the largest regional share of the nattokinase market in 2025, bolstered by established consumer familiarity with fermented soy-based products, a strong regional manufacturing base, and more routine incorporation of enzyme-based wellness products into everyday health purchasing. These conditions help sustain market activity by supporting ingredient availability, local production efficiency, and steady demand across supplement and functional health channels where nattokinase is already better recognized.
North America is projected to expand at a 3.65% CAGR over the forecast period, with growth in the nattokinase market being fueled by rising consumer interest in preventive health, broader acceptance of dietary supplements for cardiovascular wellness, and stronger product visibility across retail and e-commerce channels. Adoption is accelerating in practice as more consumers seek non-prescription wellness options and brands respond with clearer positioning, wider distribution, and more targeted education around enzyme-based formulations.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Evidence-Based SupplementsGermany places strong emphasis on ingredient quality, product transparency, and scientifically supported health supplements. Companies in Germany increasingly position nattokinase products within premium wellness portfolios targeting cardiovascular health awareness.
France 🇫🇷
Premium Nutraceutical FocusFrance emphasizes premium dietary supplements supported by quality standards and consumer confidence in natural wellness products. Nattokinase suppliers in France increasingly differentiate products through ingredient sourcing and clinically informed positioning.
Italy 🇮🇹
Natural Health FormulationsItaly shows growing interest in nattokinase products that complement preventive health and balanced lifestyle approaches. Supplement manufacturers in Italy prioritize natural formulations and product differentiation to meet evolving consumer wellness preferences.
Japan 🇯🇵
Traditional Functional NutritionJapan maintains steady demand for nattokinase through its long-standing association with fermented food traditions and functional nutrition. Manufacturers in Japan continue refining high-quality formulations while supporting innovation in health-focused supplement products.
South Korea 🇰🇷
Functional Ingredient InnovationSouth Korea expands nattokinase applications through innovation in dietary supplements and functional health products. Companies in South Korea increasingly develop convenient formulations that appeal to consumers seeking preventive cardiovascular wellness solutions.
United States 🇺🇸
Preventive Wellness DemandThe U.S. nattokinase market benefits from growing consumer interest in cardiovascular wellness and functional dietary supplements. Manufacturers in the U.S. focus on product quality, scientific positioning, and diversified supplement formulations for health-conscious consumers.
Segment Leadership and Growth Trends
Nattokinase Market Share (%), Application, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportNutraceuticals held a 47.91% share of the nattokinase market in 2025, reflecting the segment’s established role in everyday cardiovascular wellness and preventive health routines. its position is underpinned by steady consumer demand for functional supplements that are easy to incorporate into daily use, especially where nattokinase is positioned as a natural enzyme for circulatory support. The nutraceuticals segment also benefits from broad product availability across capsules, tablets, and blended formulations, which helps maintain volume demand and reinforces its leading share in the nattokinase market.
Pharmaceuticals are emerging as the fastest-growing application in the nattokinase market as interest strengthens around more clinically oriented uses of the enzyme. Growth in this segment is backed by rising attention to evidence-based cardiovascular management and the practical need for more targeted formulations with clearer therapeutic positioning than conventional supplement products. Compared with nutraceuticals, pharmaceuticals are gaining momentum because market expansion is increasingly tied to medical-use potential and structured healthcare applications rather than general wellness consumption alone.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Nutraceuticals, Food Additives, Pharmaceuticals, Others | Nutraceuticals | Pharmaceuticals |
Competitive Landscape and Market Positioning
1. Japan Bio Science Laboratory Co. Ltd. (Japan)
2. Novonesis A/S (Denmark)
3. BIO-CAT Inc. (U.S.)
4. Creative Enzymes (U.S.)
5. Daiwa Pharmaceutical Co. Ltd. (Japan)
6. Contek Life Science Co. Ltd. (China)
7. Sungen Bioscience Co. Ltd. (Taiwan)
8. Weidan Biotechnology Co. Ltd. (China)
9. Bioven Ingredients (Spain)
10. Eiffel Biotech Co. Ltd. (China)
Rising interest in enzyme-based health supplements is driving formulation diversification in functional nutrition products. The nattokinase market is evolving as research explores broader cardiovascular and wellness applications. Continuous innovation in extraction and stabilization methods is enhancing product effectiveness and consumer adoption.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| JBSL | Apr-26 | JBSL secured a patent for its NSK-SD nattokinase ingredient, reinforcing its intellectual property position in functional enzyme-based health solutions. Supported by emerging studies on blood sugar regulation and inflammation reduction, the patent strengthens commercialization prospects and enhances differentiation within the competitive nutraceutical and cardiovascular wellness ingredient market. |
| Daiken Biomedical | Feb-24 | Daiken Biomedical utilized a Japan-based patent for its triple-action health formula as part of its growth strategy. The company leverages intellectual property protection to reinforce product credibility and consumer trust, supporting expansion efforts in functional health and nutraceutical markets where differentiation and scientific validation are key competitive drivers. |
| Gnosis by Lesaffre | May-21 | Gnosis by Lesaffre acquired NattoPharma, expanding its portfolio in vitamin K2 and natto-derived health ingredients. The acquisition strengthens its position in cardiovascular and bone health nutrition segments by integrating complementary functional ingredients and broadening its ability to serve global nutraceutical markets with a more comprehensive product offering. |
| Compagnie Des Levures Lesaffre | May-21 | Compagnie Des Levures Lesaffre completed the acquisition of the remaining 23% stake in NattoPharma ASA, consolidating full ownership of the biotechnology company. The transaction strengthens Lesaffre’s control over natto-derived bioactive ingredient development and supports strategic expansion in functional health and nutraceutical ingredient markets. |
| Japan Bio Science Laboratory CO., Ltd. | Sep-24 | Japan Bio Science Laboratory unveiled its NSK-SD nattokinase enzyme at SupplySide West, highlighting its patented and clinically studied formulation. The introduction reinforces its positioning in the functional health ingredient market and supports commercialization efforts for enzyme-based nutraceutical applications targeting cardiovascular wellness. |
| Kirin Holdings | Aug-24 | Kirin Holdings and Takanofoods launched a new fermented soybean natto product incorporating Lactococcus lactis strain Plasma, aimed at supporting immune function. The product expansion reflects continued innovation in functional fermented foods, reinforcing competitive activity in health-oriented food formulations linked to cardiovascular and metabolic wellness trends. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Nattokinase Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Nattokinase Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of nattokinase?
What is the projected value of the nattokinase industry by 2035?
How is rising cardiovascular health awareness influencing consumer demand in the nattokinase market?
How are natural ingredient preferences and cross-category applications expanding market opportunities for nattokinase?
Why does Nutraceuticals dominate the nattokinase market?
Why is Pharmaceuticals the fastest-growing application in the nattokinase market?
Why does Asia Pacific dominate the nattokinase market?
Why is North America the fastest-growing nattokinase market?
Which companies dominate the nattokinase landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization